Financial Architects (New Jersey)’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-13
Closed -$3K 1546
2019
Q1
$3K Hold
13
﹤0.01% 1310
2018
Q4
$4K Buy
13
+3
+30% +$2.33K ﹤0.01% 1177
2018
Q3
$11K Sell
10
-1
-9% -$921 ﹤0.01% 1099
2018
Q2
$9K Buy
11
+3
+38% +$2.49K ﹤0.01% 1029
2018
Q1
$9K Hold
8
﹤0.01% 1129
2017
Q4
$7K Hold
8
﹤0.01% 1239
2017
Q3
$9K Sell
8
-5
-38% -$5.69K ﹤0.01% 1166
2017
Q2
$15K Sell
13
-2
-13% -$2.43K ﹤0.01% 1052
2017
Q1
$17K Buy
15
+2
+15% +$1.93K ﹤0.01% 989
2016
Q4
$13K Hold
13
﹤0.01% 959
2016
Q3
$5K Hold
13
﹤0.01% 1164
2016
Q2
$5K Buy
+13
New +$6.37K ﹤0.01% 1141

Other funds holding HSTO

Financial Architects (New Jersey)'s HSTO Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Histogen Inc. Common Stock (HSTO) in Q2 2019, closing a stake of 13 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in HSTO in Q2 2016 and held it in 12 quarters. The position peaked at $17K in Q1 2017. 36 funds tracked by Wall St. Rank hold HSTO as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining Histogen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 13 Histogen Inc. Common Stock shares in Q2 2019, an estimated $3K.
  • Financial Architects (New Jersey) first reported a position in Histogen Inc. Common Stock in Q2 2016 and held it in 12 quarters.
  • Financial Architects (New Jersey)'s Histogen Inc. Common Stock position peaked at $17K in Q1 2017.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.